Healthcare

According to a market report by Lucintel, the future of the stem cell therapy market looks promising with opportunities in the musculoskeletal disorder, wound & injury, cardiovascular disease, surgery, inflammatory & autoimmune disease, and neurological disorder applications. The global stem cell therapy market is expected to reach an estimated $0.9 billion by 2028 with a CAGR of 14.7% from 2023 to 2028. The major drivers for this market are growing number of cell therapy production facilities, increasing number of clinical trials associated with stem cell therapies, and robust government funding for stem cell research.



In this market, allogeneic stem cell therapy and autologous stem cell therapy are the major type segments. Lucintel forecasts that allogeneic stem cell therapy is expected to remain the largest type segment over the forecast period due to its increasing application in treating cancer and growing cases of cancer worldwide.



Within this market, musculoskeletal disorders is expected to witness the highest growth over the forecast period driven by the growing number of musculoskeletal disorders, such as orthopedic implant failure, cartilage repair, ligament repair, and carpal tunnel syndrome.



North America is expected to remain the largest region over the forecast period due to well-established healthcare infrastructure with advanced medical facilities, a strong regulatory framework, and development and commercialization of innovative medical technologies.

Smith+Nephew, Medipost, Anterogen, Corestem, Pharmicell NuVasive, RTI Surgical, AlloSource, JCR Pharmaceuticals, Takeda Pharmaceutical, Holostem Terapie Avanzate Srl, Orthofix, Regrow Biosciences, and Stempeutics Research are the major suppliers in the global stem cell therapy market.



Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global stem cell therapy market by type, application, and region. Lucintel has compiled a comprehensive research report titled “Growth Opportunities in the Global Stem Cell Therapy Market 2023-2028: Trends, Forecast, and Opportunity Analysis.” The Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global stem cell therapy market by type, cell source, application, and region, as follows:

This more than 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or email us at helpdesk@lucintel.com.

 

Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. Lucintel offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.

 

Q.1. What are some of the most promising, high-growth opportunities for the global stem cell therapy market by type (allogeneic stem cell therapy and  autologous stem cell therapy), cell source (adipose tissue-derived MSCs (mesenchymal stem cells), bone marrow-derived MSCs, placental/umbilical cord-derived MSCs, and others), application (musculoskeletal disorders, wounds & injuries, cardiovascular diseases, surgeries, inflammatory & autoimmune diseases, neurological disorders, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or type substitution?

Q.11. What M&A activity did occur in the last five years and how did they impact the industry?